VSee Health, Inc. VSEED
2.28
0.48
26.67%
as of 25 Sep
- Market cap
- $2.8M
- P/E
- 0.0×
Follow VSEED
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
2,466.75% | (541.52%) | (945.70%) | (1,065.78%) | |
| (46.05%) | (69.39%) | (69.53%) | (56.62%) | ||
ROIC |
0.00% | (602.00%) | (116.45%) | (93.65%) | |
Return on Tangible Assets |
52.22% | 193.99% | 199.66% | 209.77% | |
Average Days of Receivables |
77.83 | 55.96 | 67.44 | 54.42 | |
Free Cash Flow per Share |
(0.27) | (0.17) | (0.12) | (0.06) | |
Free Cash Flow |
(4.54) | (3.49) | (5.52) | (6.31) | |
Capital Expenditures |
(0.04) | (0.05) | (0.06) | — | |
Piotroski F-Score |
2.00 | 4.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
99.57% | (31.05%) | (64.59%) | (71.43%) | |
Accounts Receivable Turnover |
4.66 | 7.39 | 6.39 | 7.78 | |
Accounts Payable Turnover |
0.52 | 0.78 | 0.86 | 1.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
828.44 | 468.95 | 401.06 | 269.01 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.22 | 0.00 | (0.01) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
126.69% | 115.87% | 120.49% | 121.31% | |
Share Based Compensation of Revenue |
9.57% | 7.69% | 8.12% | 6.71% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.45 | 0.23 | 0.41 | 0.64 | |
Depreciation/Fixed assets |
6.48 | 9.00 | 9.94 | 23.09 | |
Capex/Depreciation |
(0.02) | (0.02) | (0.02) | 0.00 | |
Revenue per Share |
0.73 | 0.73 | 0.30 | 0.14 | |
Operating CF per Share |
(0.27) | (0.17) | (0.11) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(83.28%) | (100.65%) | (92.37%) | (66.11%) |
Columns are period end dates